Clinical trial

Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

NCT02485600

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-10-19

PhaseN/A

Study timeline

Study start (actual)2015-10-19Date precision: day

Registry last updated2021-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Disease (PD)unresolved

Interventions

Sponsors & collaborators

AbbVielead sponsor

Mapped research locations

MontrealQuebec, Canada2 QuébecQuebec, Canada2 TorontoOntario, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1 HamiltonOntario, Canada1 WinnipegManitoba, Canada1 SherbrookeQuebec, Canada1 KingstonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02485600 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.